Wetherby Asset Management Inc Nuvation Bio Inc. Transaction History

Wetherby Asset Management Inc

  • $2.08 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.24 - $5.85 $244,402 - $441,283
-75,433 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.6 - $8.83 $346,991 - $666,073
75,433 New
75,433 $397,000
Q3 2021

Nov 15, 2021
SELL
$7.78 - $10.0 $96,355 - $123,850
-12,385 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.22 - $14.48 $114,189 - $179,334
12,385 New
12,385 $115,000

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email